SMITHKLINE BEECHAM P has a total of 62 patent applications. Its first patent ever was published in 1996. It filed its patents most often in New Zealand. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are GRINDEKS, UNION PHARMA SCIENT APPL and NEUROCRINE BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 62 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Smith Stephen Alistair | 8 |
#2 | Craig Andrew Simon | 5 |
#3 | Thompson Mervyn | 5 |
#4 | Buckingham Robin Edwin | 4 |
#5 | Ife Robert John | 4 |
#6 | Porter Roderick Alan | 3 |
#7 | Coulton Steven | 3 |
#8 | Hickey Deirdre Mary Bernadette | 3 |
#9 | Pinto Ivan Leo | 3 |
#10 | Parker David Myatt | 3 |
Publication | Filing date | Title |
---|---|---|
NZ535261A | A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide | |
NZ511614A | Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin | |
NZ510672A | Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione | |
NZ506200A | Use of a leptine sensitiser in combination with leptin to treat leptine resistance conditions (e.g. obesity) | |
NZ502434A | Aminoguanidine for treating niddm |